ATI LPN
ATI LPN Pharmacology 2023 retake 1 Questions
Extract:
Question 1 of 5
A nurse is caring for a client who has chronic renal failure and is receiving epoetin alfa. To check for therapeutic effects, the nurse should monitor which of the following client laboratory tests?
Correct Answer: A
Rationale: The correct answer is A: Hemoglobin levels. Epoetin alfa stimulates red blood cell production, increasing hemoglobin levels in clients with chronic renal failure who often have anemia. Monitoring hemoglobin levels helps assess the effectiveness of the medication. Iron levels (
B) are important for erythropoiesis but not directly affected by epoetin alfa. Platelet count (
C) and white blood cell count (
D) are not specifically related to the therapeutic effects of epoetin alfa in chronic renal failure.
Question 2 of 5
A nurse is reinforcing teaching with a client who is to start therapy with furosemide. The nurse determines that the teaching is effective when the client states he will increase intake of which of the following foods?
Correct Answer: B
Rationale: The correct answer is B: Baked potatoes. Furosemide is a loop diuretic that can lead to potassium depletion. Baked potatoes are high in potassium, which can help prevent hypokalemia associated with furosemide therapy. Oatmeal, brown rice, and eggs are not particularly high in potassium and would not be the best choice for increasing potassium intake. By choosing baked potatoes, the client can help maintain adequate potassium levels while on furosemide therapy.
Question 3 of 5
A charge nurse is evaluating a newly licensed nurse caring for a client who is using a PCA device. Which of the following actions by the nurse requires intervention by the charge nurse?
Correct Answer: D
Rationale:
Correct
Answer: D. The nurse administering a PCA dose for the client requires intervention. This is because only the client should be allowed to self-administer medication via a PCA device to ensure safety and prevent medication errors. Allowing the nurse to administer the dose goes against the principles of PCA therapy, which empowers the client to manage their pain relief within safe limits.
Choice A: Monitoring the client for oversedation is a standard nursing practice and does not require intervention.
Choice B: Reassuring the client about the PCA device is important for patient education but does not require immediate intervention.
Choice C: Asking the client to demonstrate dose delivery is a proactive approach to ensure the client understands how to use the device correctly and does not require intervention unless the client is unable to demonstrate understanding.
Question 4 of 5
A nurse is monitoring a client's response to receiving glipizide instead of guaifenesin. Which of the following actions should the nurse take?
Correct Answer: C
Rationale: The correct answer is C: Offer the client a carbohydrate snack. Glipizide is an oral antidiabetic medication that can lower blood sugar levels by stimulating the release of insulin from the pancreas. If the client receives glipizide instead of guaifenesin (an expectorant), there is a risk of hypoglycemia due to the medication's blood sugar-lowering effects. Offering a carbohydrate snack can help prevent or treat hypoglycemia by quickly raising blood sugar levels. Lowering the head of the bed (
A), checking for urinary retention (
B), and testing deep-tendon reflexes (
D) are not directly related to the client's response to glipizide.
Question 5 of 5
A nurse is reviewing the medication administration record of a client who has a wound infection. The client has prescriptions for cefotetan and an NSAID. The nurse should monitor for which of the following medication interactions?
Correct Answer: A
Rationale: The correct answer is A: Bleeding. Cefotetan is a cephalosporin antibiotic that can increase the risk of bleeding when taken with NSAIDs due to their additive effects on platelet function. The combination can lead to gastrointestinal bleeding or bruising. Dysrhythmias (choice
B) are not typically associated with this drug combination. Dizziness (choice
C) and jaundice (choice
D) are not common interactions with cefotetan and NSAIDs.